drugset / Trial / NCT03937687
The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement
Phase 0
Completed
49 enrolled
University of South Carolina
Compound Solutions Inc. · collabRutgers, The State University of New Jersey · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this randomized, placebo-controlled, three-condition, double-blind, between-subjects clinical trial is to determine and compare the effects of the combination of TeaCrine®, Dynamine, and caffeine to a placebo and caffeine condition on reaction time and target acquisition and accuracy. A secondary purpose is to observe the changes in hemodynamic variables in response to this combination.
Timeline
- Start
- 2019-05-04
- Primary completion
- 2020-11-15
- Completion
- 2020-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amifampridine | Small molecule | 100 mg | — |
| Subject | Caffeine | Small molecule | 150 mg | — |
| Subject | Caffeine | Small molecule | 300 mg | — |
| Subject | TeaCrine | Unknown | 50 mg | — |
Indications
No indication recorded.